NEW YORK, May 10, 2022--(BUSINESS WIRE)--As part of its ambition and commitment to unlock opportunities for growth and good across the entire healthcare ecosystem, dentsu health announced today two key senior appointments. To elevate dentsu health’s research and audience capabilities, Data Scientist Olympia Mantsios has been appointed Global VP Data & Analytics. And, to accelerate the transformation of dentsu health’s product offerings, Lynda Gordon will join as SVP, Product Development.
About dentsu international
Part of dentsu, dentsu international is made up of six leadership brands - Carat, dentsu X, iProspect, Isobar, dentsumcgarrybowen, Merkle, and supported by its specialist brands. Dentsu International helps clients to win, keep and grow their best customers and achieve meaningful progress for their businesses. With best-in-class services and solutions in media, CXM and creative, dentsu international operates in over 145 markets worldwide with more than 45,000 dedicated specialists. www.dentsu.com
About dentsu health
Dentsu health is an integrated solution that is transforming the healthcare agency services model through a global teaming platform of 2,000+ experts, specializing in health, wellness and pharmaceutical marketing.
Dentsu health unites leadership across our global agency brands in data and technology with a deep understanding of the emotional territory of healthcare, equips brands to connect with the right audience at the right moment, but always with ideas that speak to the heart. https://dentsuhealth.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20220510006031/en/
For more information reach out to: Kate Dobrucki, VP Communications, dentsu international | 416-347-3059 | email@example.com